• Aztreonam’s Role in Deciphering Gram-Negative Resistance Dyn

  2026-04-27

  Explore how Aztreonam, a monocyclic β-lactam antibiotic, is revolutionizing research on Gram-negative aerobic bacteria and multidrug resistance. This article uniquely connects molecular mechanism, resistance gene mobility, and advanced assay design for a new era of antibiotic research.

• Genetic and Media Optimization Boosts A40926 Antibiotic Yiel

  2026-04-27

  This study demonstrates a combined genetic engineering and media optimization approach to substantially increase production of the glycopeptide antibiotic A40926 in Nonomuraea gerenzanensis. The findings provide actionable strategies for improving yields of valuable antibiotics, with implications for industrial and research-scale biosynthesis.

• MRSA: Mechanisms of Resistance and Implications for Research

  2026-04-26

  This review by Turner et al. synthesizes decades of clinical and molecular research on methicillin-resistant Staphylococcus aureus (MRSA), clarifying the genetic and epidemiological factors driving its persistence and global spread. The findings underscore the importance of understanding mecA-mediated resistance for advancing both basic infection models and clinical management strategies.

• CA-074 and Cathepsin B: Unveiling Necroptosis Control Points

  2026-04-25

  Explore how the cathepsin B inhibitor CA-074 enables precise dissection of necroptosis and metastatic processes. This article uniquely integrates mechanistic breakthroughs with assay optimization guidance, advancing research beyond standard applications.

• Gepotidacin vs. Nitrofurantoin: Phase 3 Advances in UTI Ther

  2026-04-24

  The EAGLE-2 and EAGLE-3 trials evaluated gepotidacin, a first-in-class triazaacenaphthylene antibiotic, against nitrofurantoin for uncomplicated urinary tract infections. The results demonstrated gepotidacin’s non-inferiority and, in one trial, superiority, offering important evidence for expanding the antibiotic arsenal amid rising resistance.

• KU-60019: ATM Kinase Inhibitor Workflows for Glioma Radiosen

  2026-04-24

  KU-60019 empowers researchers to precisely disrupt ATM kinase signaling, unlocking new potential for glioma radiosensitization and DNA damage response inhibition. This guide delivers actionable protocols, troubleshooting strategies, and evidence-backed insights for maximizing experimental impact with KU-60019.

• Moxidectin: Bridging Antiparasitic and Antifungal Frontiers

  2026-04-23

  This thought-leadership article explores how moxidectin, traditionally a macrocyclic lactone anthelmintic for veterinary and human parasitic worm control, is now poised to transform antifungal strategies. We blend mechanistic insight—highlighting moxidectin’s ergosterol-elevating synergy with polyene antifungals in Candida albicans—with strategic guidance for translational researchers seeking cross-domain innovation. By critically reviewing recent literature and practical protocols, we clarify how APExBIO’s high-purity moxidectin offers a new research avenue beyond standard product pages.

• Type III Collagen as a Tumor-Restrictive Matrix in Breast Ca

  2026-04-23

  This study uncovers a critical tumor-suppressive function for type III collagen (Col3) in the breast cancer microenvironment, showing that higher Col3:Col1 ratios correlate with improved patient survival. The findings highlight Col3's potential as a prognostic marker and therapeutic target, with implications for designing new anti-recurrence strategies in breast cancer.

• Cefazedone (Refosporen): Method-Driven Advances in Antibacte

  2026-04-22

  Explore the pivotal role of Cefazedone (Refosporen) in methodological innovation for antibacterial testing and clinical translation. This article uniquely details advanced assay protocols, validated pharmacokinetics, and practical guidance for researchers.

• 3X (DYKDDDDK) Peptide: Unveiling Mechanisms in Protein Ubiqu

  2026-04-22

  Explore how the 3X (DYKDDDDK) Peptide advances affinity purification and structural studies, with new insight into its role in interactome analysis and protein ubiquitination. This article provides a deep-dive into scientific applications that set the 3X FLAG peptide apart.

• Advanced Signal Amplification: HRP Goat Anti-Mouse IgG (H+L)

  2026-04-21

  Explore how the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated, transforms assay sensitivity and reliability. This article offers a unique, evidence-driven perspective on mechanistic signal amplification and practical protocol optimization.

• SP1/ADAM10/DRP1 Axis Mediates EC–SMC Crosstalk in Hypoxic PH

  2026-04-21

  This study illuminates the SP1/ADAM10/DRP1 signaling axis as a molecular bridge in the pathological communication between endothelial and smooth muscle cells during hypoxia-induced pulmonary hypertension (HPH). By dissecting the mechanistic role of DRP1-mediated mitochondrial dynamics in smooth muscle cell phenotype under hypoxic stress, the research identifies actionable targets for modulating pulmonary vascular remodeling.

• Hydroxytyrosol: Optimizing Antioxidant Assays for Cardiovasc

  2026-04-20

  Hydroxytyrosol, a potent olive oil-derived phenolic antioxidant, streamlines advanced in vitro workflows for cardiovascular, inflammation, and oncology research. Here, we detail practical protocols, troubleshooting insights, and translational advantages leveraging APExBIO’s high-purity Hydroxytyrosol (SKU N2302).

• Optimizing Immunoassays with c-Myc tag Peptide: Protocols &

  2026-04-20

  The c-Myc tag Peptide from APExBIO enables precise displacement of c-Myc-tagged fusion proteins and delivers robust anti-c-Myc antibody binding inhibition. This guide explores advanced workflow enhancements, protocol parameters, and stepwise troubleshooting, bridging experimental immunoassay needs with cutting-edge research on transcription factor regulation.

• Protease Inhibitor Cocktail (EDTA-Free): Precision in Virus-

  2026-04-19

  Explore how the Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers viral infection studies by ensuring protein integrity, with an in-depth look at its unique compatibility with DMSO-driven differentiation and advanced virology models. Learn why this serine protease inhibitor is pivotal for robust, reproducible protein extraction workflows.

448 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page